Injectable Drug Delivery News

  1. scPharmaceuticals Announces FDA Approval Of FUROSCIX® (Furosemide Injection) 10/11/2022

    scPharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has approved FUROSCIX® (furosemide injection), a proprietary formulation of furosemide delivered via an On-Body Infusor for the treatment of congestion due to fluid overload in adults with New York Heart Association Class II/III chronic heart failure.

  2. Aktiv Pharma Group To Participate In The FDA Emerging Technology Program 9/26/2022

    Aktiv Pharma Group (Aktiv) announced today the acceptance of its novel glass-free, film-based flexible primary drug container (PDC) technology for sterile injectables named ARCH, into the US Food and Drug Administration (FDA) Emerging Technology Program (ETP)

  3. ten23 Health Completes The Superstructure Of Their New Large-Scale Sterile Production Facility In Visp, Switzerland 9/19/2022

    With the initial phase of construction now complete, ten23 will commence with interior construction andhiring of further team members. The sterile manufacturing plant is well on track to be operational in 2024 for global commercial supplies of injectable drugs

  4. Grand River Aseptic Manufacturing To Fill And Finish Smallpox/Monkeypox Vaccines And Accelerate Domestic Supply 8/19/2022

    Grand River Aseptic Manufacturing (“GRAM”), a prominent parenteral drug product contract development and manufacturing organization (CDMO), has entered into an agreement with Bavarian Nordic, a Denmark-based vaccine company, to fill and finish JYNNEOS smallpox/monkeypox vaccine

  5. Grand River Aseptic Manufacturing Completes Phase II Expansion With Installation Of Two New Sterile Filling Lines 8/17/2022

    Grand River Aseptic Manufacturing (“GRAM”), a prominent parenteral drug product contract development and manufacturing organization (CDMO), has completed Phase II of its facility expansion which includes the installation of GRAM’s two new sterile Bausch+Ströbel filling lines

  6. West Makes Minority Investment In Dublin-Based Latch Medical, A Developer Of Vaccine And Biologics Delivery Platforms 8/15/2022

    West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced it has made a strategic investment in Latch Medical, a Dublin-based leader in next-generation vaccine and biologics delivery technology that is pioneering a new approach to intradermal delivery.

  7. Landec Corporation Announces Intention To Become Lifecore Biomedical 8/10/2022

    Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials – today formally announced the Company’s path forward as a CDMO-focused life sciences company, complete with a planned corporate rebranding, new ticker symbol, and the naming of its go-forward executive leadership team and Board of Directors

  8. Genixus Receives Federal Registration & State Licensing To Begin Production Of KinetiX™ Ready-To-Administer (RTA) Syringe Platform For Acute And Critical Care Medicines 8/3/2022

    Genixus, a pharmaceutical company focused on transforming acute and critical care medicines, today announced that it has received both federal registration and state licensing to begin commercial production of its new KinetiX™ RTA Platform brand of pre-filled syringes

  9. Evonik Now Offers Enteric Protected Ready To Fill Capsules EUDRACAP In IPEC GMP Quality 7/27/2022

    Evonik’s EUDRACAP enteric easy-to-handle capsules are now globally available produced under IPEC-GMP. Launched last year, EUDRACAP enteric are functional, ready-to-fill capsules that help pharmaceutical companies bring complex oral drug products to market faster

  10. Novavax Announces Expanded Agreement With SK Bioscience To Manufacture COVID-19 Vaccine Containing Omicron Variant And Manufacture The Novavax COVID-19 Vaccine In Prefilled Syringes 7/19/2022

    Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, has signed agreements with its partner, SK bioscience, for the manufacturing and supply of a version of the Novavax COVID-19 vaccine (NVX-CoV2373) containing Omicron variant and for the manufacture of the vaccine in prefilled syringes